Efficacy and safety of JNJ-42165279, a fatty acid amide hydrolase inhibitor, in adolescents and adults with autism spectrum disorder: a randomized, phase 2, placebo-controlled study
Matthew Klein, Abigail Bangerter, Robin Halter, Kim Cooper, Zuleima Aguilar, Carla M. Canuso, Wayne C. Drevets, Mark E. Schmidt, Gahan Pandina
Topics & Concepts
PlaceboAutismAutism Diagnostic Observation SchedulePsychologyAnxietyAutism spectrum disorderInternal medicineAdverse effectRandomized controlled trialPsychiatryMedicinePathologyAlternative medicineAutism Spectrum Disorder ResearchCannabis and Cannabinoid ResearchChild Nutrition and Feeding Issues